AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23553157
Drug: High-sodium diet
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-sodium diet (3.8 g/d)
Trial: 8991493
Drug: 2 x
RxNorm normalized name: anti-HER2 x HER2 ADC
DrugBank: Zanidatamab zovodotin (DB15472)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 x 25 mg clomipramine hydrochloride tablets (Noristan Ltd.)
Trial: 8991493
Drug: Anafranil 2
RxNorm normalized name: Anafranil 25mg Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anafranil 2 x 25 mg tablets (clomipramine HCl; Ciba‐Geigy (Pty) Ltd.)
Trial: 8991493
Drug: 5 x
RxNorm normalized name: PAD,ABDOMINAL 5 X 9 STERILE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 x 10 mg clomipramine hydrochloride tablets (Noristan Ltd.)
Trial: 8991493
Drug: Anafranil 5
RxNorm normalized name: Anafranil 50mg Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anafranil 5 x 10 mg tablets (clomipramine HCl; Ciba‐Geigy (Pty) Ltd.)
Trial: 1389190
Drug: Thiopental with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental with infusion of sufentanil 0.1 microgram/kg/hr
Trial: 1389190
Drug: Thiopental with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental with infusion of fentanyl 1 microgram/kg/hr
Trial: 1389190
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of 0.25% to 2% isoflurane
Trial: 3999630
Drug: Antihypertensive drugs
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive drugs (including diuretics)
Trial: 30473540
Drug: Liraglutide injection:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide injection: 0.6‐1.2 mg/day, 12 weeks, n=52
Trial: 30473540
Drug: Metformin (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (oral metformin: 1000‐1500 mg/day, 12 weeks, n=75)
Trial: 12393986
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with or without radiotherapy (26 epirubicin, 19 epirubicin + ifosfamide)
Trial: 15658903
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with or without radiotherapy
Trial: 10654875
Drug: 5.0 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.0 mg/day bisoprolol
Trial: 10654875
Drug: 2.5 mg/day
RxNorm normalized name: Androderm 2.5 MG/Day 24 HR Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg/day bisoprolol
Trial: 10654875
Drug: Healthy control
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Healthy control subjects receiving 5.0 mg/day bisoprolol
Trial: 30472215
Drug: CST-AET (Coping
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CST-AET (Coping Skills Training for Adherence to Endocrine Therapy)
Trial: 27787700
Drug: Desmopressin (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desmopressin (0.4 mg) and Indomethacin (50 mg)
Trial: 25919012
Drug: Men with
RxNorm normalized name: Peptamen with Prebio Vanilla
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Men with HIV plasma VL > 50,000 copies/ml
Trial: 21250973
Drug: Revaccination with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Revaccination with non-live vaccines after chemotherapy, starting as early as 3 months post-chemotherapy.
Trial: 19283649
Drug: Physical exercise;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical exercise; details on dosage and duration not available
Trial: 10965639
Drug: Psychotherapy treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychotherapy treatment for BED
Trial: 1291593
Drug: Vaginal micronized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal micronized progesterone (4 g of vaginal cream containing 2.5% natural progesterone)
Trial: 27741123
Drug: Robot-assisted gait
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Robot-assisted gait therapy (RAGT) combined with rehabilitation therapy (RT)
Trial: 27741123
Drug: Rehabilitation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rehabilitation therapy (RT) alone
Trial: 18514630
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid (AA) treatment, 70.6 kcal/day (8 g of essential AAs) given at 10:00 am and 5:00 pm
Trial: 18514630
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid (AA) treatment
Trial: 12417888
Drug: Chlorpheniramine 8
RxNorm normalized name: CODEINE 54.3/CHLORPHENIRAMINE 8MG SA TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpheniramine 8 mg
Trial: 1790403
Drug: Sodium fluoride
RxNorm normalized name: Sodium Fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium fluoride (NaF) 75 mg/day
Trial: 30431567
Drug: Shaft method
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shaft method to place biological mesh
Trial: 27208320
Drug: GLIPULIN (exenatide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLIPULIN (exenatide dosing before meals)
Trial: 27208320
Drug: BBI (rapid-acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BBI (rapid-acting insulin analogs)
Trial: 20464583
Drug: Zolmitriptan (Z)
RxNorm normalized name: Zolmitriptan
DrugBank: Zolmitriptan (DB00315)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zolmitriptan (Z) 2.5 mg
Trial: 16003228
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) 1.5 g administered twice daily with CNI dose reduction or discontinuation (group 1: discontinuation, group 2: 50% reduction)
Trial: 16003228
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (CNI dose reduction or discontinuation without MMF)
Trial: 12534449
Drug: Fluvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin (40 mg day-1)
Trial: 8542860
Drug: Injection speed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Injection speed of 10 seconds
Trial: 8542860
Drug: Injection speed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Injection speed of 20 seconds
Trial: 8542860
Drug: Injection speed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Injection speed of 30 seconds
Trial: 8542860
Drug: Injection speed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Injection speed of 1 minute (added group)
Trial: 21371282
Drug: Antiplatelet therapy:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiplatelet therapy: 325 mg aspirin daily plus 75 mg clopidogrel daily
Trial: 21371282
Drug: Antiplatelet therapy:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiplatelet therapy: 325 mg aspirin daily plus placebo
Trial: 19621985
Drug: Cyclosporin A
RxNorm normalized name: Cyclosporin A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin A (CsA) 5 mg/kg infused over 24 h
Trial: 15124801
Drug: Methylprednisolone (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (6 mg/kg BW, administered intravenously in six equal doses at 8 h intervals)
Trial: 11786156
Drug: WMS ≤16%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WMS ≤16% with ICD treatment
Trial: 8271851
Drug: Thrombolysis followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thrombolysis followed by conservative therapy
Trial: 2574053
Drug: Phenytoin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenytoin (100 mg intravenously)
Trial: 28284776
Drug: 20 and
RxNorm normalized name: zinc pyrithione 20 MG/ML [Free and Clear]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 and 35 mg/kg GHB
Trial: 28284776
Drug: 35 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35 mg/kg GHB
Trial: 23489776
Drug: Selenium 200
RxNorm normalized name: SELENIUM 200MCG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium 200 μg/day
Trial: 23489776
Drug: Selenium 400
RxNorm normalized name: selenium 400 MCG in 10 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium 400 μg/day
Trial: 21733952
Drug: Cilostazol (low-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilostazol (low-dose 100 mg/d)
Trial: 21733952
Drug: Cilostazol (high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilostazol (high-dose 200 mg/d)
Trial: 16988754
Drug: Losartan 100
RxNorm normalized name: LOSARTAN 100MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 100 mg + Amlodipine 5 mg
Trial: 11192339
Drug: Preventive occupational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive occupational therapy (OT) for 9 months
Trial: 9720932
Drug: Intra-arterial infusion
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial infusion of doxorubicin
Trial: 7999406
Drug: naproxen 1500
RxNorm normalized name: Naproxen
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: naproxen 1500 mg
Trial: 7999406
Drug: slow-release morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: slow-release morphine 60 mg
Trial: 3213896
Drug: Buflomedil 600
RxNorm normalized name: buflomedil 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buflomedil 600 mg.d-1 in association with anti-edema drugs
Trial: 3213896
Drug: Anti-edema drugs
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-edema drugs only
Trial: 28666299
Drug: Trimethoprim 80
RxNorm normalized name: trimethoprim 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim 80 mg and Sulfamethoxazole 400 mg
Trial: 28666299
Drug: Nitrofurantoin 100
RxNorm normalized name: nitrofurantoin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrofurantoin 100 mg
Trial: 24262593
Drug: Fenoverine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoverine (100 mg three times a day)
Trial: 24262593
Drug: Trimebutine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimebutine (150 mg three times a day)
Trial: 16548939
Drug: Maximal tailored
RxNorm normalized name: Spirulina maxima preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maximal tailored behavioral treatment (baseline tailored brief motivational intervention, quit date behavioral skills counseling session, relapse prevention follow‐up session)
Trial: 16548939
Drug: Minimal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimal treatment (brief advice using the National Cancer Institute's 4 As model)
Trial: 8728305
Drug: Nifedipine SR
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine SR 20 mg twice daily
Trial: 92897
Drug: No injections
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No injections (Control group)
Trial: 92897
Drug: Immunotherapy (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy (both treatment groups)
Trial: 31775650
Drug: Care coordination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Care coordination intervention involving practical nurses trained to assess medication risks and coordinating with pharmacists and physicians.
Trial: 25098557
Drug: Normal Protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal Protein (NP) breakfast (350 kcal, 13 g protein)
Trial: 25098557
Drug: High Protein
RxNorm normalized name: Vital High Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High Protein (HP) breakfast (350 kcal, 35 g protein)
Trial: 17466735
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of botulinum toxin type A (Botox) (200 or 300 U)
Trial: 15983826
Drug: Aprepitant (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprepitant (125 mg on day 1, 80 mg on days 2 and 3)
Trial: 11997270
Drug: Oral conjugated
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral conjugated equine estrogen (0.625 mg/d)
Trial: 11997270
Drug: Estrogen plus
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen plus progestin (medroxyprogesterone acetate 2.5 mg/d)
Trial: 9806688
Drug: 0.75% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75% bupivacaine (1.5 mL)
Trial: 9806688
Drug: 1% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% bupivacaine (1.125 mL)
Trial: 7714743
Drug: Formulation A
RxNorm normalized name: meningococcal vaccine of unknown formulation and unknown serogroups
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formulation A (IPA/water/IPM; 11:7:1)
Trial: 7714743
Drug: Formulation B
RxNorm normalized name: Hep B, unspecified formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formulation B (ET/PG/IPM; 11:7:2)
Trial: 7714743
Drug: Formulation C
RxNorm normalized name: Army Liposome Formulation component monophosphoryl lipid A
DrugBank: Monophosphoryl lipid A (DB19290)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formulation C (IPM/capmul)
Trial: 3066620
Drug: Mazindol 2
RxNorm normalized name: mazindol 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mazindol 2 mg
Trial: 28682871
Drug: Enzalutamide (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enzalutamide (160 mg/d)
Trial: 25627820
Drug: Goshajinkigan (GJG)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goshajinkigan (GJG) 7.5 mg three times daily
Trial: 20709498
Drug: Intravenous nicorandil
RxNorm normalized name: nicorandil
DrugBank: Nicorandil (DB09220)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous nicorandil (0.2 mg/kg/5 min bolus followed by continuous infusion at 0.05, 0.10, or 0.20 mg/kg/h for 6h)
Trial: 3150319
Drug: Intranasal buserelin
RxNorm normalized name: buserelin
DrugBank: Buserelin (DB06719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal buserelin 400 micrograms three times daily for 6 months
Trial: 3150319
Drug: Post-treatment (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-treatment (6 months after stopping buserelin)
Trial: 3150319
Drug: During treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: During treatment with buserelin
Trial: 30668196
Drug: Serum anti-Müllerian
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum anti-Müllerian hormone (AMH) levels measured using VIDAS®
Trial: 30668196
Drug: AMH cutoff
RxNorm normalized name: Sodium Fluoride 0.007 mg in 35 mL ORAL SPRAY [AMHEALER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMH cutoff value of 42.1 pmol/L
Trial: 19103558
Drug: Silymarin, 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silymarin, 2 x 166 mg/day for 3 months
Trial: 17928596
Drug: Colonization with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colonization with S. pneumoniae, M. catarrhalis, H. influenzae, or a combination of these organisms
Trial: 15385732
Drug: AMD3100 (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMD3100 (all doses)
Trial: 11519973
Drug: Iron-fortified cow's
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron-fortified cow's milk (7.0 or 14.9 mg Fe l(‐1))
Trial: 9683847
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy with cisplatin and adriamycin
Trial: 9683847
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy with ifosfamide and etoposide added to cisplatin and adriamycin for poor histologic response
Trial: 29352071
Drug: Aggressive diuresis
RxNorm normalized name: hydralazine hydrochloride / hydrochlorothiazide / reserpine Oral Tablet [Diuretic Ap-Es]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aggressive diuresis with high-dose loop diuretics (median 560 mg IV furosemide equivalents)
Trial: 29352071
Drug: Aggressive diuresis
RxNorm normalized name: hydralazine hydrochloride / hydrochlorothiazide / reserpine Oral Tablet [Diuretic Ap-Es]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aggressive diuresis with high-dose loop diuretics
Trial: 27510532
Drug: Oral Nutritional
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Nutritional Supplementation (ONS) during HD sessions for 12 weeks
Trial: 27510532
Drug: Oral Nutritional
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Nutritional Supplementation (ONS) + Resistance Exercise (RE) during HD sessions for 12 weeks
Trial: 24992949
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone for 8 days in tapering doses
Trial: 24992949
Drug: Intratympanic prednisolone
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intratympanic prednisolone at a dose of 62.5 mg/ml once a day for 3 consecutive days
Trial: 22995032
Drug: Olive oil
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olive oil applied twice daily for 5 weeks
Trial: 22995032
Drug: Sunflower seed
RxNorm normalized name: SUNFLOWER SEED
DrugBank: Sunflower seed (DB10907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sunflower seed oil applied twice daily for 4 weeks
Trial: 18232726
Drug: High-dose olanzapine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose olanzapine (mean dose, 34 mg/day)
Trial: 18232726
Drug: Clozapine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clozapine (mean dose, 564 mg/day)
Trial: 11860612
Drug: Norepinephrine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norepinephrine (10 micrograms in 0.1 ml saline)
Trial: 11860612
Drug: Saline (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (0.1 ml)
Trial: 1772457
Drug: Hemodialysate injection
RxNorm normalized name: ferric pyrophosphate
DrugBank: Ferric pyrophosphate citrate (DB13995)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hemodialysate injection (10 ml, 400 mg)
Trial: 1772457
Drug: Hemodialysate infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hemodialysate infusion (500 ml, 4 g)
Trial: 28822007
Drug: 3 ×
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 × 3 dose-dense cycles of intensified epirubicin, paclitaxel, and cyclophosphamide (ETC)
Trial: 28822007
Drug: 4 cycles
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 cycles concurrent epirubicin and cyclophosphamide followed by 10 cycles of weekly paclitaxel combined with 4 cycles capecitabine (EC-TX)
Trial: 28822007
Drug: ETC treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ETC treatment
Trial: 24227635
Drug: Sertraline 50mg
RxNorm normalized name: sertraline 50 MG
DrugBank: Sertraline (DB01104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sertraline 50mg
Trial: 22558108
Drug: Ready-to-use therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ready-to-use therapeutic food (RUTF) - daily supplemental RUTF (high-protein peanut-based paste) for 14 days
Trial: 11442499
Drug: Clodronate (1600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clodronate (1600 mg/d)
Trial: 2150785
Drug: Single administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single administration of 250 mg of caffeine (a)
Trial: 2150785
Drug: Continuous administration
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous administration of 250 mg caffeine per day for 5 days (c)
Trial: 25134312
Drug: Moisturising leave‐on
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moisturising leave‐on lotion (LOL) containing 10% glycerol, applied 3 times per week for 8 weeks.
Trial: 12637480
Drug: Intravenous irinotecan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous irinotecan plus oral ciclosporin
Trial: 12730797
Drug: SR 1
RxNorm normalized name: SR 140333
DrugBank: SR 140333 (DB05790)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR 1 g/day
Trial: 12730797
Drug: SR 2
RxNorm normalized name: Calan SR 240mg Extended-Release Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR 2 g/day
Trial: 12730797
Drug: SR (higher-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR (higher-dose group)
Trial: 8675080
Drug: Cisapride (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride (10 mg four times daily orally)
Trial: 1736933
Drug: Chlorthalidone (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone (25 mg/daily) with weight loss
Trial: 1736933
Drug: Atenolol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (50 mg/daily) with weight loss
Trial: 1736933
Drug: Sodium restriction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium restriction (reduced sodium to less than 70 mEq daily)
Trial: 6228913
Drug: Aspirin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (1 g) + Dipyridamole (225 mg)
Trial: 26407603
Drug: ABT-436 100
RxNorm normalized name: ABT-925
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-436 100 mg